|
|
|
|
| Advertisement |
 |
|
| Special Feature |
 |
|
Pharm Exec’s Top 50 Companies |
Our 20th annual listing highlights brand surges, new ranking battles, and M&A-sparked upswings, but in the shadow of COVID-19, a peek behind the numbers also tells another story
… /Read more/ |
|
|
| Advertisement |
Innovation and Perseverance: Bringing a New Delivery Method to Market
The road to development for a unique formulation of an oral testosterone replacement therapy was a long one. Robert E. Dudley, PhD, Chairman, Chief Executive Officer and President at Clarus Therapeutics, Inc. talks about what this process was like and the hurdles the company faced launching amid the COVID-19 pandemic.
Access the Podcast and Q&A
|
| COVID-19 |
 |
|
Post-COVID World Demands More Than AI |
A crisis like COVID-19 is not one event, but many interconnected crises. If we’re not constantly learning and adapting, we’re going to be facing a long, painful recovery. We need to modernize how we operate, writes Derek Choy
… /Read more/ |
|
|
| Advertisement |
Beyond EDC – Don’t Just Capture Data, Collect It
Tuesday, June 23, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Access the Podcast and Q&A
|
| |
|
|
|
|
|
|
|
|
| Advertisement |
Powering HCP Promotional Precision and ROI Using AI & Predictive Analytics: A practical overview of how to use AI & ML with patient-level data to improve HCP targeting, call planning and messaging
Thursday, June 18, 2020 at 11am EDT
Register now
|
| |
| Industry update |
| //Stanley Lapidus, founder and former Chairman & CEO of Exact Sciences, joined PAVmed Subsidiary Lucid Diagnostics (New York, NY) as Strategic Advisor
//Boehringer Ingelheim (Ridgefield, CT) announced that Dr. Wolfgang Baiker, US Country Managing Director, President and CEO, is to retire after 31 years’ service to the company on July 31, 2020. Jean-Michel Boers has been appointed to succeed him.
//Urovant Sciences (Irvine, CA, and Basel, Switzerland) announced the appointment of Walt Johnston as Senior Vice President of Commercial and Kenton Stewart as Senior Vice President of Market Access, both reporting to Urovant CEO James Robinson.
|
|
|
|
|
|
|
|
|
|
|
